单氨基神经递质是tau聚合的双模效应剂
Xinmin Chang1, Amanda M Tse1, Marina Fayzullina1
1Department of Pharmacology and Pharmaceutical Sciences, USC Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Science advances
|January 31, 2025
概括
神经递质 (NTs) 可以抑制蛋白聚合,这是神经退行性疾病的关键因素. 调节NT水平可能为大脑疾病提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 神经递质 (NTs) 对于细胞信号传递至关重要,它们的失调与衰老和大脑疾病有关.
- 蛋白质聚合,特别是涉及陶纤维,是神经退行性疾病的标志,如阿尔茨海默氏症.
研究的目的:
- 研究NTs在调节细胞内蛋白质聚合中的新型作用.
- 识别抑制或催化蛋白质聚合的特定NT,并了解它们的机制.
主要方法:
- 基于细胞的播种实验被用来研究NTs与蛋白纤维的相互作用.
- 小分子的化学类型被用来确定聚合抑制和催化作用的决定因素.
- 进行了剂量反应研究,以分析NTs对纤维素分解和播种的影响.
主要成果:
- 单氨基性NTs被确定为tau聚合的抑制剂.
- NTs表现出双式效应:低度的聚合催化和高度的抑制播种.
- 这些双模效应在体外和多巴胺作用神经元中被观察到.
结论:
- NTs在蛋白质聚合中具有双重作用,根据度起到催化剂和抑制剂的作用.
- 这些发现表明,NTs可以影响细胞内蛋白质聚合环境.
- 针对细胞内NT水平的药物疗法可能被开发用于管理神经退行性疾病.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Role of Neurotransmitters in Memory
399
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
399
Excitatory and Inhibitory Effects of Neurotransmitters
9.7K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.7K
Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183


